Northern Trust Corp Gilead Sciences, Inc. Transaction History

Northern Trust Corp

$572 Billion
Q1 2024

A detailed history of Northern Trust Corp transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 13,229,268 shares of GILD stock, worth $921 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

13,229,268

Previous 14,025,898 5.68%

Holding current value

$921 Million

Previous $1.14 Billion 14.71%

% of portfolio

0.17%

Previous 0.21%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $57 Million - $69.5 Million	-796,630 Reduced 5.68%	13,229,268 $969 Million
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $65.7 Million - $74.5 Million	-896,590 Reduced 6.01%	14,025,898 $1.14 Billion
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $37.3 Million - $40.7 Million	504,475 Added 3.5%	14,922,488 $1.12 Billion
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $10 Million - $11.4 Million	-131,813 Reduced 0.91%	14,418,013 $1.11 Billion
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $30.4 Million - $34.6 Million	-392,670 Reduced 2.63%	14,549,826 $1.21 Billion

Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $22.4 Million - $32.1 Million	-359,122 Reduced 2.35%	14,942,496 $1.28 Billion
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $687,746 - $785,583	-11,551 Reduced 0.08%	15,301,618 $944 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $19.9 Million - $22.4 Million	343,918 Added 2.3%	15,313,169 $947 Million
Q1 2022 May 13, 2022	BUY	$57.92 - $72.58 $25 Million - $31.3 Million	430,810 Added 2.96%	14,969,251 $890 Million
Q4 2021 Feb 08, 2022	BUY	$64.88 - $73.64 $3.92 Million - $4.45 Million	60,475 Added 0.42%	14,538,441 $1.06 Billion
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $40.8 Million - $44 Million	-602,918 Reduced 4.0%	14,477,966 $1.01 Billion
Q2 2021 Aug 13, 2021	SELL	$63.47 - $69.35 $3.06 Million - $3.35 Million	-48,262 Reduced 0.32%	15,080,884 $1.04 Billion
Q1 2021 May 12, 2021	SELL	$60.0 - $68.46 $6.88 Million - $7.85 Million	-114,683 Reduced 0.75%	15,129,146 $978 Million
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $34.5 Million - $39.3 Million	-609,237 Reduced 3.84%	15,243,829 $888 Million
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $14.2 Million - $17.8 Million	-228,140 Reduced 1.42%	15,853,066 $1 Billion
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $38.1 Million - $44.2 Million	526,283 Added 3.38%	16,081,206 $1.24 Billion
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $7.05 Million - $9.03 Million	112,564 Added 0.73%	15,554,923 $1.16 Billion
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $104 Million - $114 Million	-1,687,348 Reduced 9.85%	15,442,359 $1 Billion
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $3.63 Million - $4 Million	-58,034 Reduced 0.34%	17,129,707 $1.09 Billion
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $21.5 Million - $24.1 Million	347,443 Added 2.06%	17,187,741 $1.16 Billion
Q1 2019 May 13, 2019	SELL	$62.53 - $70.05 $9.21 Million - $10.3 Million	-147,343 Reduced 0.87%	16,840,298 $1.09 Billion
Q4 2018 Feb 12, 2019	BUY	$60.54 - $79.0 $23.1 Million - $30.1 Million	380,928 Added 2.29%	16,987,641 $1.06 Billion
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $15.4 Million - $17.1 Million	-216,479 Reduced 1.29%	16,606,713 $1.28 Billion
Q2 2018 Sep 18, 2018	SELL	$64.88 - $75.68 $5.8 Million - $6.77 Million	-89,444 Reduced 0.53%	16,823,192 $1.19 Billion
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $26.9 Million - $31.4 Million	414,690 Added 2.51%	16,912,636 $1.2 Billion
Q1 2018 May 09, 2018	SELL	$72.84 - $88.8 $15.1 Million - $18.4 Million	-206,790 Reduced 1.24%	16,497,946 $1.24 Billion
Q4 2017 Feb 14, 2018	SELL	$71.15 - $83.52 $23.7 Million - $27.8 Million	-333,007 Reduced 1.95%	16,704,736 $1.2 Billion
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $1.23 Billion - $1.46 Billion	17,037,743	17,037,743 $1.38 Billion

Others Institutions Holding GILD

# of Institutions

1,884

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $87.2B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Gilead Sciences, Inc. Transaction History